CytoDyn CYDY
OTC CYDY
$0.25 0.00 (-1.77%)
As of: Oct 21, 2026 · 12:21 PM EDT

CytoDyn (CYDY) EV to EBITDA (2024 - 2025)

Updated

CytoDyn's EV to EBITDA came in at 42.65 for fiscal Q4 2025 (quarter ended May 31, 2025), down 5.4% from the prior quarter.

Analysis

CytoDyn (CYDY) EV to EBITDA (2024 - 2025) Analysis & Trends

Going back to fiscal Q1 2025, CytoDyn's EV to EBITDA data covers 4 quarters.

  • The five-year range for quarterly EV to EBITDA is 13.01 (fiscal Q2 2025) to 45.08 (fiscal Q3 2025).
  • Business Quant data shows CYDY's EV to EBITDA at 45.08 (Q3 2025), 13.01 (Q2 2025) and 17.53 (Q1 2025) in the three fiscal quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CytoDyn 340.03 Mn 291.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 40.93
Feb 28, 2025 42.59
Nov 30, 2024 11.95
Aug 31, 2024 16.10
API Access

CytoDyn EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CYDY&period=max&api_key=YOUR_API_KEY